Hualan Biological Vaccine Inc Class A 301207
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥16.91
- Day Range
- ¥17.17–18.47
- 52-Week Range
- ¥15.42–36.00
- Bid/Ask
- ¥18.07 / ¥18.08
- Market Cap
- ¥10.87 Bil
- Volume/Avg
- 6.9 Mil / 3.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.58
- Price/Sales
- 4.43
- Dividend Yield (Trailing)
- 3.55%
- Dividend Yield (Forward)
- 3.55%
- Total Yield
- 3.55%
Company Profile
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 770
- Website
- http://www.hualanbacterin.com
Comparables
Valuation
|
Metric
|
301207
|
300122
|
300149
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.58 | 9.77 | — |
Price/Book Value | 1.72 | 1.84 | 2.11 |
Price/Sales | 4.43 | 1.24 | 2.68 |
Price/Cash Flow | 10.76 | 8.06 | 21.83 |
Price/Earnings
301207
300122
300149
Financial Strength
|
Metric
|
301207
|
300122
|
300149
|
|---|---|---|---|
Quick Ratio | 2.85 | 1.37 | 1.46 |
Current Ratio | 3.42 | 2.07 | 1.71 |
Interest Coverage | 149.96 | 76.85 | −32.05 |
Quick Ratio
301207
300122
300149
Profitability
|
Metric
|
301207
|
300122
|
300149
|
|---|---|---|---|
Return on Assets (Normalized) | 9.24% | 11.64% | −34.73% |
Return on Equity (Normalized) | 11.52% | 19.62% | −54.47% |
Return on Invested Capital (Normalized) | 10.82% | 17.67% | −38.80% |
Return on Assets
301207
300122
300149
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Dkqndxstx | Bxw | $554.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Rnhrpwxkt | Jlchtwc | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Xyxkgwc | Phdgb | $114.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Crqppyyw | Hhbmgr | $35.2 Bil | |||
| argenx SE ADR
ARGX
| Zcwzpzrdc | Gkm | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Xfbhvyp | Ttnz | $28.0 Bil | |||
| Moderna Inc
MRNA
| Bqjqthmv | Ddf | $24.6 Bil | |||
| United Therapeutics Corp
UTHR
| Ygmktwf | Gyvhw | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Mptmdybl | Hsvkfzp | $13.4 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Kfhqtvkbwv | Hvmch | $12.6 Bil |
United States